Copy number variation (CNV) is a common form of structural variation detected in human genomes, occurring as both constitutional and somatic events. Cytogenetic techniques like chromosomal microarray (CMA) are widely used in analyzing CNVs. However, CMA techniques cannot resolve the full nature of these structural variations (i.e. the orientation and location of associated breakpoint junctions) and must be combined with other cytogenetic techniques, such as karyotyping or FISH, to do so. This makes the development of a next-generation sequencing (NGS) approach capable of resolving both CNVs and breakpoint junctions desirable. Mate-pair sequencing (MPseq) is a NGS technology designed to find large structural rearrangements across the entire genome. Here we present an algorithm capable of performing copy number analysis from mate-pair sequencing data. The algorithm uses a stepwise procedure involving normalization, segmentation, and classification of the sequencing data. The segmentation technique combines both read depth and discordant mate-pair reads to increase the sensitivity and resolution of CNV calls. The method is particularly suited to MPseq, which is designed to detect breakpoint junctions at high resolution. This allows for the classification step to accurately calculate copy number levels at the relatively low read depth of MPseq. Here we compare results for a series of hematological cancer samples that were tested with CMA and MPseq. We demonstrate comparable sensitivity to the state-of-the-art CMA technology, with the benefit of improved breakpoint resolution. The algorithm provides a powerful analytical tool for the analysis of MPseq results in cancer.
accurate way for CNVs to be detected is through an array-based comparative genomic hybridization (aCGH) or SNP-based microarrays, collectively described as chromosomal microarray (CMA). 10, 11 In brief, CMA provides an assessment of copy number in a sample genome by hybridization parameters compared to a reference, either by competitive hybridization of differentially labeled genome (aCGH) or by comparison to an in silico reference (SNP-based microarray). This allows for the detection of alterations in copy number throughout the genome at 20-50 kb resolution using the highest density arrays, and even greater resolution with high-density tiling of probes. 10, [12] [13] [14] [15] While CMA offers state-of-the-art CNV detection at high resolution, there are also inherent advantages that NGS solutions offer.
NGS encompasses the broad advances in sequencing technology that allow for fast sequencing on the whole-genome scale. Mate-pair sequencing (MPseq) technology is one such whole-genome sequencing (WGS) method. MPseq is designed to allow for paired-end sequencing of large DNA fragments (2-5 kb) through the use of a modified library preparation. 16 The longer fragments allow for the accurate determina- In this study we present our CNV detection algorithm, called
CNVDetect, which consists of normalization, segmentation, classification, and visualization steps. The segmentation of the genomic data into copy number regions, also referred to as step detection, is ubiquitous in CNV detection algorithms. 17 Most NGS methods employ either a sliding window [18] [19] [20] or a global approach like a Hidden Markov Model (HMM). 21 Here we employ a sliding window approach in the interest of speed. Typically such approaches have the drawback of being lowresolution, being limited by the window size used and the ability to effectively capture the necessary statistics. However, MPseq provides breakpoint locations at 200 bp resolution for large structural rearrangements (gains or losses >30 kb). 22 By integrating the discordant mate-pair reads into the algorithm we are able to effectively increase breakpoint resolution. In this way our method is unique in that it is optimized to take advantage of the high-resolution breakpoint information naturally provided by the MPseq NGS technology at low read depth coverage. Such methods have previously been developed for use with high read-depth paired-end sequencing data. 23 This accurate breakpoint location information is especially important in analyzing cancer genome samples where normal cell contamination and minor clones often make precise CNV determination difficult.
We present results from the CNV algorithm compared to 26 samples run using the CMA technique. We assess how the inclusion of break- 
| Cytogenetics chromosomal microarray analysis
Chromosomal microarray was performed on all samples using the CytoScan HD array (Affymetrix, Santa Clara, CA) according to the manufacturer's protocol. Data were analyzed using the manufacturer-provided software (ChAS) with the following laboratory defined parameters:
Default smooth and join settings were turned off. All copy number segments were flagged for review when involving at least 25 markers for deletions and 50 markers for duplications. Additionally, all microarray data were manually reviewed to dismiss artifactual calls, refine CNV breakpoints called by the software, as well as to identify additional subtle copy number variation that was not flagged by the algorithm.
Such manual calling practices are widely used in clinical microarray review. 24 Chromosomal microarray data were reviewed according to standard clinical protocols, and only those CNV segments meeting laboratory clinical reporting criteria were evaluated against MPseq in this study.
| DNA library preparation and sequencing
DNA was isolated using the Qiagen Puregene extraction protocol. The DNA was processed using the Illumina Nextera Mate Pair library protocol and sequenced on the Illumina HiSeq 2000. Pooled libraries were hybridized per flow cell and sequenced using 101-basepair reads and paired-end sequencing.
| BMD structural variant pipeline
The analysis pipeline for MPseq sequencing data was developed to find breakpoint junction locations and CNVs. The pipeline is termed the BMD Structural Variant Pipeline (BMD SV Pipeline) and is depicted in Figure  F1 1A. It takes as input the MPseq sequencing data detailed in the DNA library preparation protocol and performs a 2-step process: alignment and structural variant analysis. Alignment is performed using the BIMA alignment method. 25 The mapped sequences are passed to the SVAtools module, which consists of a breakpoint junction detection step 22 and a CNV detection step. This CNV detection step, termed
CNVDetect, requires both the alignment and breakpoint junction detection steps to be performed before analysis can be completed.
The CNVDetect algorithm for determining CNVs in MPseq data was designed to proceed through 4 steps, normalization, segmentation, classification, and visualization ( Figure 1B ) to account for the following factors: (1) the variation in copy number level due to structural or sequence biases, such as GC content, (2) the presence of normal cell contamination, and (3) the presence of heterogeneous subclones with differing CNVs. Factor (1) has the potential to increase the false positive rate of the algorithm, while factors (2) and (3) have the potential to increase the false negative rate.
CNVs are detected using the read count of concordant mapping fragments from MPseq sequencing data aligned using the BIMA alignment method. 25 The first step of the algorithm aims to normalize the sample read count data using a previously sequenced normal genome sample that closely resembles the sample of interest. This step is designed to take into account all sequence, structural, or DNA processing biases that may contribute to variations in read count that do not reflect the signal of interest. The method does not rely on sequence data, such as GC content, to account for bias, but rather leverages existing genomic knowledge.
The second step of the algorithm segments the genomic data into copy number regions. It uses a sliding window algorithm for step detection, repeated for bin sizes ranging from 100 kb to 1 Mb. All positions with statistically significant changes in read depth are considered possible edges of CNV regions. We increase the edge detection resolution by incorporating breakpoint junctions detected in the SVAtools 22 to supplement the statistically determined edges.
The third step of the algorithm takes the potential copy number regions and classifies them as loss, gain, or normal copy state. It is assumed that through segmentation the data within a copy number region belong to the same probability distribution. This probability distribution for the region is estimated and the peak of the distribution is taken as the expected read depth for the region. The raw number of CNV calls and the number of CNV calls that pass the respective filters are presented in Table  T1 1 and a full set of CMA final number of reported CNV calls is considerably smaller than either the filtered CMA analysis or filtered CNVDetect analysis produces. Our method often produces a higher number of filtered CNV calls than the CMA filter, but on the same order, and the reasons for this are further described in the Discussion section along with strategies that could be employed to reduce the number. The CMA analysis reports a higher raw number of CNVs than CNVDetect, as there is no restriction on the size of a CNV call in the raw CMA analysis.
Since our gold standard used a manual review to produce the final set of reported CNVs, the final analysis of our method focused only on these reported CNV locations. We aimed to determine whether these same CNV locations were called using MPseq The raw number of CNV calls output by both the CMA method and CNVDetect for each of the 26 patient samples are reported. These raw sets of CNVs are then filtered and the resulting number of CNVs is provided under the CMA Filter and CNV Filter heading. The final number of CNV calls reported using the clinical CMA analysis with manual review is provided for comparison. a This sample failed QC in CMA processing, but was still analyzed for CNV reporting. If no such region in the genome was found, a false negative was reported.
Overall we found that there were 107 CNVs reported by the cytogenetics laboratory in the 26 relevant patient cases. All but 10 were CNVDetect and had to be considered a false negative (EV88089) and 1 event had MP and CNVDetect support for being a normal copy number region rather than the loss reported in the CMA data (EV88103).
When analyzing the boundaries of the CNV regions it was found that our method covered >95% of the copy number calls in all but 6 of the calls. In these cases the discrepancy was due to regions with high homology or low probe density for CMA (centromere, telomere, or segmental duplication regions) where the CNV boundary location is difficult to determine in both methods.
All comparisons to CMA are limited to the CNV calls reported after manual cytogenetic analysis, as far more regions in any given genome will be predicted as a loss or gain by the CMA analysis software (ChAS) than will ultimately be reported (Table 1) . However, we also allow for CNVDetect to calculate a variant cutoff value based on the noise detected in the sample and automatically make loss and gain calls, much like how filters are used in reporting raw CMA results. These results would still need to be manually curated to account for false positives due to noise, homology, etc., but provide a basis for visualization.
An example of a visual representation of these CNVDetect results is
presented as a genome plot Figure  F2 2A for sample EV88086. Figure 2B . This is also a good example of where the fuller context of breakpoint junctions and read-depth analysis allow for the reporting of CNVs that may not be considered significant enough for reporting through CMA alone. Note that in Figure 2A there is a small deletion in chromosome 2 connected to the complex event on chromosome 11 (connecting magenta lines in Figure 2A ). While the gain and loss on chromosome 11 are reported in CMA (Table 2) , this connecting loss is not. With the full context on how this complex event occurs, the deletion on chromosome 2 can be reported by MPseq.
This visualization of the CNV results highlights the major benefit of CNVDetect compared to other CNV detection methods, including the CMA method. SVAtools calculates and reports the location of breakpoint junctions within a sample (magenta lines in Figure 2A ).
CNVDetect has been designed to use the breakpoint locations from these junctions to segment the genome into potential CNV regions.
The SVAtools algorithm will provide breakpoint locations at 200 bp resolution for >90% of the breakpoint junctions in a sample. This ability to combine breakpoint and CNV information also allows for the ability to correctly call CNVs that are connected by a complex event that is not apparent by CMA or karyotyping alone. Figure  F4 4A is a complex event that was initially characterized by karyotyping as 46,XY,t(5;6)(q13;q23) [10] /47,XY,112 [2] /46,XY [8] , with half of the cells demonstrating a t(5;6) translocation. From CMA, the deletions on chromosome 6 were called (EV88059 in Table   2 ), but little can be done from the information to fully elucidate the translocation and how the aberrant genome comes together.
Shown here in

With the combination of the SVAtools breakpoint locations
CNVDetect is able to correctly call a small deletion in chromosome 5, which is not called by CMA, and elucidate where each breakpoint of the t(5;6) translocation resides (magenta lines in Figure 4A ). With the additional breakpoint junction information, this small deletion on chromosome 5, which was not significant enough to be reported through CMA analysis, was connected to the larger, more complex event. This context makes reporting through MPseq analysis straightforward. Note also that this is a case where the breakpoint junction detection module in SVAtools did not report a breakpoint junction that connects the proximal deletion in chromosome 6 to the distal deletion (green arrows in Figure   4A ). Despite the lack of breakpoint information in those 2 locations, CNVDetect was still able to call the CNVs by relying on the more tradi- In this way we are able to report CNVs with higher accuracy than Further, if the method were to be used to detect copy number variants on a large region, whole-arm, or whole-chromosome level, the statistical methods could be tailored to the region size and the lower limit could be further reduced. At the moment, the method has been developed to detect copy number variants down to 100kb size, without consideration of how detection could be improved for known variant locations. Along with continued improvement of the resolution and sensitivity of the algorithm future avenues of research will aim to produce a head-to-head comparison of MPseq/CNVDetect and CMA, where the method's sensitivity will be assessed without prior knowledge of CMA results.
As MPseq becomes more widely used, the sample preparation and sequencing will be further optimized to improve the quality and readdepth of the data used in the CNVDetect algorithm. This improvement in data quality could also reduce the lower limit of detection. Theoretically, the underlying statistical distribution for the read depth data is a Poisson distribution. Any increase or decrease in read depth should not affect the performance of CNV detection given this distribution as the mean and standard deviation both increase and decrease linearly at the same rate. However, particularly for low read depth cases like we have using MPseq technology, higher read depth will improve the sensitivity of the method due to a reduction in detection size. As read depth increases, smaller windows can be used in the copy number variant detection, and the increased available data will allow for more sensitive CNV detection and the detection of smaller CNVs. Additionally, increased read depth will increase the bridged-coverage for a sample and increase the sensitivity for breakpoint junction detection. This would allow for increased CNV edge resolution for a sample, and help increase the performance of the method, particularly in cases with low tumor cellularity. Such read depth dependent performance is typical for any read-based CNV detection method, however the use of both breakpoint junctions and read depth in the CNV calculation helps mitigate this effect compared to many other methods.
Much can be learned from comparing the CNVDetect results to a manually curated CMA output. Both the CMA method without manual review and our algorithmic CNV detection method are prone to reporting false positives, as demonstrated by the considerably higher number of CNV calls made by both CMA and CNVDetect as compared to the final number of Reported CNV calls (Table 1) . In CMA analysis these excluded CNV calls often result from sequencing and hybridization artifacts and polymorphisms that may make reported results difficult to analyze. Alternately, CNVDetect reports a higher number of CNV calls after filtering for 2 reasons. The first is that since we are dealing with NGS data there are sequencing biases that must be dealt with prior to CNV calling. We use a normalization step to reduce this bias (see Section 2) but for lower quality samples with abnormal levels of bias, normalization can be difficult and incorrect CNVs calls can result. Further sequencing of normals will make such failures in normalization more rare by better covering the sample landscape. Additionally, the incorporation of bias correction, such as GC bias correction, into the method could aid in reducing the effect of sequencing bias rather than relying only on matching normal samples.
The second reason CNVDetect reports a higher number of CNV calls is that our method often segments a single reportable CNV region 
